Atlas Trials

Real-World Outcome of Rheumatoid Arthritis Patients in Korea on Adalimumab

Clinical trial NCT02627924 · COMPLETED

Trial details

NCT number
NCT02627924
Sponsor
AbbVie
Status
COMPLETED
Study type
OBSERVATIONAL
Rheumatoid Arthritis
Start date
2015-11-18
Primary completion
2017-12-28
Enrollment
91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.